Chemoinformaics analysis of 3, 4- dihydroxybenzoic acid
| Molecular Weight | 334.288 | nRot | 1 |
| Heavy Atom Molecular Weight | 320.176 | nRig | 12 |
| Exact Molecular Weight | 334.091 | nRing | 3 |
| Solubility: LogS | -1.815 | nHRing | 2 |
| Solubility: LogP | 0.153 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 1 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 4 | No. of Arom Atom | 15 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 16 |
| nHA | 8 | APOL | 41.9271 |
| nHD | 4 | BPOL | 21.7789 |
| QED | 0.562 |
| Synth | 2.544 |
| Natural Product Likeliness | -0.75 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.079 |
| Pgp-sub | 0.981 |
| HIA | 0.007 |
| CACO-2 | -4.957 |
| MDCK | 0.00000483 |
| BBB | 0.88 |
| PPB | 0.502675 |
| VDSS | 1.38 |
| FU | 0.549736 |
| CYP1A2-inh | 0.236 |
| CYP1A2-sub | 0.975 |
| CYP2c19-inh | 0.023 |
| CYP2c19-sub | 0.349 |
| CYP2c9-inh | 0.005 |
| CYP2c9-sub | 0.834 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.069 |
| CYP3a4-inh | 0.029 |
| CYP3a4-sub | 0.79 |
| CL | 2.256 |
| T12 | 0.828 |
| hERG | 0.012 |
| Ames | 0.022 |
| ROA | 0.982 |
| SkinSen | 0.058 |
| Carcinogencity | 0.067 |
| EI | 0.236 |
| Respiratory | 0.872 |
| NR-Aromatase | 0.006 |
| Antiviral | Yes |
| Prediction | 0.631184 |